Navigation Links
Severe alcoholic hepatitis: An effective combination of 2 treatments
Date:11/10/2011

Acute alcoholic hepatitis is one of the most serious forms of alcoholic liver disease, affecting individuals with chronic excessive alcohol consumption, which generally equates to more than 50 grams of alcohol per day (roughly five drinks), over a period of more than three to six months. The disease is characterized by liver failure (hepatic insufficiency) and acute jaundice (icterus), which may induce a coma through liver failure (hepatic encephalopathy) and an ensuing death rate of between 40-45% within the first six months. Conventional treatment involves stopping alcohol consumption (alcohol abstinence) and administering cortisone (corticosteroid therapy over a one-month period) to fight the highly inflammatory nature of the disease. Despite this treatment, 30-35% of patients with acute alcoholic hepatitis still die within a six month period, since the cortisone-based treatment remains insufficient.

Given the given the frequent deficiency in the antioxidant capacity of the alcoholic liver (described above), combined with chronic inflammation associated with the disease, the aim of the study coordinated by Professor Nguyen-Khas (Amiens University Hospital Centre and the Inserm research team) was to combine an antioxidant treatment with the conventional anti-inflammatory treatment. The results show an improved survival rate for patients suffering from acute alcoholic hepatitis who were given both medication types, with significantly less deaths within one month of treatment compared to the group who received the cortisone- only treatment. Tolerance levels to the treatment were good. The new, very low-cost medicine (N-acetylcysteine) is a molecule that has long been used in the treatment of hepatitis caused by drugs such as paracetamol, or mucolytic to fluidify bronchial secretion.

These results improve the prognosis for severe alcoholic hepatitis patients.


'/>"/>
Contact: Inserm Presse
presse@inserm.fr
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Page: 1

Related medicine news :

1. Imaging technique IDs plaques, tangles in brains of severely depressed older adults
2. Researchers identify potential risk factors for severe altitude sickness
3. Minority children less likely to wear a car seatbelt, putting them at greater risk of severe injury
4. Folic acid supplements in early pregnancy may reduce the risk of severe language delay in children
5. Oral steroids linked to severe vitamin D deficiency in nationwide study
6. HRT therapy appears to increase risk of hospitalization from severe asthma attacks
7. Vitamin D deficiency linked with airway changes in children with severe asthma
8. One-Third of Severe Heart Attack Patients Have Treatment Delays
9. Estrogen treatment may help reverse severe pulmonary hypertension
10. New Drug May Relieve Severe, Tough-to-Treat Gout
11. Anti-Clotting Drug May Cause Severe Bleeding With No Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... With a ... have raised more than $15,000 in just a couple of weeks for those ... matches and world-class instructor seminars, organizers expect to double those initial funds with ...
(Date:9/19/2017)... ... September 19, 2017 , ... PAPA ... Vincent’s Infusion Services called, “PAPA Healthcare helps fill gaps, provide essential insights, and ... service delivery and operations by leveraging PAPA Healthcare’s post-acute productivity and analytics solutions. ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... joined its executive team as the President of its HealthBI division. McFarland ... systems and contact centers. , “Scott is a utility player who balances ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... of Canyon Ranch to its recently formed Corporate Roundtable, a group ... healthcare system and a sustainable world. , Canyon Ranch is a unique collection ...
(Date:9/19/2017)... Chevy Chase, MD (PRWEB) , ... September 19, ... ... last week, the Society of Professional Benefit Administrators (SPBA) hosted “Expanding ... learning opportunities for SPBA Members as it focused on best practices for third ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months ... Insight is pleased to announce the appointment of three ... Tammy Wynne , Dominic Jones-Phillips and ... industry. Tammy ... team of market access writers. She has over ten ...
(Date:9/1/2017)...  Bayer will present the latest research from across its ... (ESMO) 2017 Congress, September 8-12 in Madrid, Spain ... clinical data on Bayer,s marketed portfolio and late-stage compounds as ... "We value the opportunity to ... at ESMO," said Carsten Brunn , Head of Pharmaceuticals, ...
(Date:8/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will present ... 11, 2017, in New York . ... scheduled to present at 11:05 a.m. Eastern Time. ... http://ir.hill-rom.com/events.cfm . A recorded replay will be available one hour ... 2017. About Hill-Rom ...
Breaking Medicine Technology: